Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Feb 8, 2020
Date Accepted: Jun 22, 2020
Date Submitted to PubMed: Jul 14, 2020

The final, peer-reviewed published version of this preprint can be found here:

The Need to Develop Standard Measures of Patient Adherence for Big Data: Viewpoint

Kardas P, Aguilar-Palacio I, Marta A, Cahir C, Costa E, Giardini A, Malo S, Massot Mesquida M, Menditto E, Midão L, Parra-Calderón CL, Pepiol Salom E, Vrijens B

The Need to Develop Standard Measures of Patient Adherence for Big Data: Viewpoint

J Med Internet Res 2020;22(8):e18150

DOI: 10.2196/18150

PMID: 32663138

PMCID: 7484771

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

We need patient adherence standard measures for Big Data.

  • Przemyslaw Kardas; 
  • Isabel Aguilar-Palacio; 
  • Almada Marta; 
  • Caitriona Cahir; 
  • Elísio Costa; 
  • Anna Giardini; 
  • Sara Malo; 
  • Mireia Massot Mesquida; 
  • Enrica Menditto; 
  • Luis Midão; 
  • Carlos Luis Parra-Calderón; 
  • Enrique Pepiol Salom; 
  • Bernard Vrijens

ABSTRACT

Despite half a century of dedicated studies, medication adherence remains far from perfect, with many patients not taking their medications as prescribed. The magnitude of this problem is rising, jeopardizing the effectiveness of evidence-based therapies. An important reason for this is the unprecedented demographic change at the beginning of 21st century. Ageing leads to multimorbidity and complex therapeutic regimens that create fertile ground for non-adherence. As this scenario is a global problem, it needs a worldwide answer. Might we find this answer thanks to new opportunities created by the digitization of healthcare? Day by day health-related information is collected in electronic health records, pharmacy dispensing databases, health insurance systems and national health system records. These Big Data repositories offer an unprecedented opportunity to study adherence both retrospectively and prospectively, at the population level, as well as its related factors. If only we had widely accepted standard measures of adherence, we could use this data to inform health research, clinical practice and public health. These standards could also help us to better understand the relationship between adherence and clinical outcomes, and allow for fair benchmarking of effectiveness and cost-effectiveness of adherence-targeting interventions. Unfortunately, despite this obvious need, we are still far from having sound standards of formatting, and analyzing Big Data in order to assess, uniformly present and compare patterns of medication adherence across studies. The aim of this paper is to call for producing such consensus standards, in order to help adherence, and make healthcare systems more effective and sustainable.


 Citation

Please cite as:

Kardas P, Aguilar-Palacio I, Marta A, Cahir C, Costa E, Giardini A, Malo S, Massot Mesquida M, Menditto E, Midão L, Parra-Calderón CL, Pepiol Salom E, Vrijens B

The Need to Develop Standard Measures of Patient Adherence for Big Data: Viewpoint

J Med Internet Res 2020;22(8):e18150

DOI: 10.2196/18150

PMID: 32663138

PMCID: 7484771

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.